👤 M Losekoot

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
2
Articles
2
Name variants
Also published as: Monique Losekoot
articles
Willemijn F E Kuper, Claudia van Alfen, Linda van Eck +5 more · 2020 · JIMD reports · Wiley · added 2026-04-24
CLN3 disease is a disorder of lysosomal homeostasis predominantly affecting the retina and the brain. The severity of the underlying mutations in We present three patients with an identical Contrastin Show more
CLN3 disease is a disorder of lysosomal homeostasis predominantly affecting the retina and the brain. The severity of the underlying mutations in We present three patients with an identical Contrasting our initial expectations, patients with a start codon variant in Show less
📄 PDF DOI: 10.1002/jmd2.12097
CLN3
P E M Taschner, M Losekoot, M H Breuning +2 more · 2005 · Nederlands tijdschrift voor geneeskunde · added 2026-04-24
The neuronal ceroid lipofuscinoses (NCL) are worldwide the most common lysosomal storage disorders of childhood. Clinical features often include progressive visual impairment, seizures, psychomotor de Show more
The neuronal ceroid lipofuscinoses (NCL) are worldwide the most common lysosomal storage disorders of childhood. Clinical features often include progressive visual impairment, seizures, psychomotor deterioration, dementia, and premature death. Most NCL cases are caused by mutations in the CLN1, CLN2 and CLN3 genes, which play an essential role in lysosomal protein degradation. Laboratory diagnostics for a patient suspected of NCL should start with enzyme analysis in the case of INCL and LINCL and investigation of lymphocyte vacuolisation for JNCL. Diagnosis at the protein level is not available for JNCL, but CLN3 mutation analysis is possible. The carrier status of healthy relatives in families with known mutations in either CLN1, CLN2, CLN3 or CLN6 can be determined with certainty by mutation analysis. Show less
no PDF
CLN3